Teladoc Health, Inc. (TDOC)

Teladoc Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	2,619	2,602	2,407	2,033	1,094	553.31
Revenue Growth (YoY)	6.01%	8.13%	18.41%	85.81%	97.71%	32.40%
Cost of Revenue	764.46	760.03	743.99	650.26	390.83	184.47
Gross Profit	1,855	1,842	1,663	1,382	703.13	368.84
Selling, General & Admin	1,371	1,367	1,301	1,105	886.88	339.07
Research & Development	342.92	348.52	333.63	311.88	164.94	64.64
Other Operating Expenses	399.23	375.12	13,682	230.88	157.73	45.57
Operating Expenses	2,113	2,091	15,316	1,648	1,210	449.28
Operating Income	-258.57	-248.55	-13,653.21	-265.63	-506.42	-80.44
Interest Expense / Income	22.67	22.28	21.94	81.14	59.95	29.36
Other Expense / Income	-50.98	-51.23	-11.82	37.88	9.62	-0.34
Pretax Income	-230.26	-219.61	-13,663.34	-384.66	-575.99	-109.46
Income Tax	2.77	0.76	-3.81	44.14	-90.86	-10.59
Net Income	-233.03	-220.37	-13,659.53	-428.79	-485.14	-98.86
Shares Outstanding (Basic)	168	165	161	157	91	72
Shares Outstanding (Diluted)	168	165	161	157	91	72
Shares Change	2.95%	1.93%	2.88%	73.40%	25.98%	9.11%
EPS (Basic)	-1.41	-1.34	-84.60	-2.73	-5.36	-1.38
EPS (Diluted)	-1.41	-1.34	-84.60	-2.73	-5.36	-1.38
Free Cash Flow	199.55	193.67	16.53	130.06	-79.55	18.97
Free Cash Flow Per Share	1.19	1.18	0.10	0.83	-0.88	0.26
Gross Margin	70.81%	70.80%	69.09%	68.01%	64.27%	66.66%
Operating Margin	-9.87%	-9.55%	-567.27%	-13.07%	-46.29%	-14.54%
Profit Margin	-8.90%	-8.47%	-567.53%	-21.09%	-44.35%	-17.87%
Free Cash Flow Margin	7.62%	7.44%	0.69%	6.40%	-7.27%	3.43%
EBITDA	170.72	154	-13,370.76	-83.89	-437.96	-35.15
EBITDA Margin	6.52%	5.92%	-555.53%	-4.13%	-40.03%	-6.35%
Depreciation & Amortization	378.31	351.32	270.64	219.62	78.09	44.95
EBIT	-207.59	-197.33	-13,641.4	-303.52	-516.04	-80.1
EBIT Margin	-7.93%	-7.58%	-566.78%	-14.93%	-47.17%	-14.48%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).